Patents by Inventor Clarence D. Cone, Jr.

Clarence D. Cone, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4935450
    Abstract: A method for effecting oncolysis, regression, and control of malignant neoplasms in humans and other mammals without adverse effects on normal body cells is described. An ATP-availability depressor may be combined with a defined nutritional regimen, a fatty acid blocker, an amino acid blocker, a lactate export blocker, or any combination thereof.
    Type: Grant
    Filed: August 22, 1988
    Date of Patent: June 19, 1990
    Assignee: Therapeutical Systems Corporation
    Inventor: Clarence D. Cone, Jr.
  • Patent number: 4724234
    Abstract: A method of producing oncolysis and regression of malignant tumors and other malignant conditions without adverse effects on normal body cells is described. A calorically and compositionally defined nutritional regimen providing a minimum of amino acids and fatty acids and a maximum of carbohydrates is administered concurrently with a drug regimen of an agent or agents that uncouple oxidative phosphorylation, most preferably 2,4-dinitrophenol.
    Type: Grant
    Filed: October 28, 1985
    Date of Patent: February 9, 1988
    Assignee: Therapeutical Systems Corp.
    Inventor: Clarence D. Cone, Jr.
  • Patent number: 4724230
    Abstract: An improved method is described for producing oncolysis, including regression of malignant tumors or other malignant conditions, without adverse effects upon normal body cells. In addition to a calorically and compositionally defined nutritional regimen providing a minimum of amino acids and fatty acids and a maximum of carbohydrate, administered concurrently with a drug regimen of an agent or agents that uncouple oxidative phosphorylation (most preferably 2,4-dinitrophenol), there is also concurrently administered a selected amount of a substantially non-toxic fatty acid oxidation inhibitor capable of effectively lowering the mitochondrial .beta.-oxidation rate of fatty acids.
    Type: Grant
    Filed: July 25, 1984
    Date of Patent: February 9, 1988
    Assignee: Therapeutical Systems Corp.
    Inventor: Clarence D. Cone, Jr.
  • Patent number: 4018649
    Abstract: A method of controlling mitosis of biological cells by inducing a change in the intracellular ionic hierarchy accompanying the cellular electrical transmembrane potential difference (E.sub.m) of the cells. The ionic hierarchy may be varied by imposing changes on the relative concentrations of Na.sup.+, K.sup.+, and Cl.sup.-, or by directly imposed changes of the physical E.sub.m level across the cell surface.
    Type: Grant
    Filed: October 17, 1975
    Date of Patent: April 19, 1977
    Inventor: Clarence D. Cone, Jr.